Fonar enters Nasdaq good graces

Article

Dedicated MR vendor Fonar is in compliance with the Nasdaq stock exchange, ending concerns that the company would be delisted.

Fonar enters Nasdaq good graces
Dedicated MR vendor Fonar is in compliance with the Nasdaq stock exchange, ending concerns that the company would be delisted. At issue was whether Fonar satisfied Nasdaq Listing Rule 5550(b)(3), which requires companies on the exchange to have a minimum $500,000 of net income from continuing operations in the latest fiscal year. Fonar’s most recent Form 10-K, filed Oct. 5, showed net income from continuing operations of $1.1 million for the fiscal year ended June 30, 2009.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.